Ulrike Gerdemann MD

Dr. Ulrike Gerdemann obtained her MD from Charité University in Berlin, Germany. She spent two years of medical school working with Anja Troeger and Dagmar Dillo on creating dendritic cell leukemia vaccines. She then completed two-and-a-half years of pediatrics residency at Heinrich Heine University in Düsseldorf, followed by five years of postdoctoral training at Baylor University, where she worked with Malcolm Brenner, an expert in stem cell transplantation. She developed and clinically translated new cell-based therapies to treat viral infections in transplant recipients. She was able to achieve an 80% response rate in patients with life-threatening viral infections that were resistant to conventional therapies. Ulrike is a Boston Combined Residency Program (BCRP) resident in the Integrated Research Pathway and worked with Nick Haining on whether prolonged in vivo culture of T-cells alters their epigenetic state, "aging" them prematurely.